Alpa Labs - Alpa Laboratories Share Price

67.58-0.54 (-0.78%)

Closed
As On: 22 Jun, 2026, 03:45 PM IST
As On: 22 Jun, 2026, 03:50 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	69.80
High	69.80
Low	67.20
Prev Close	68.11
Volume	12,878
VWAP(₹)	67.79

Share Price	Value
Today/Current/Last	67.5867.48
Previous Day	68.1167.88

Alpa Labs Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Alpa Labs Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	31.24	29.96	29.32	31.06	42.40
Total Income Growth (%)	4.27	2.18	-5.60	-26.75	21.30
Total Expenses	28.90	28.18	29.17	19.24	40.30
Total Expenses Growth (%)	2.55	-3.39	51.61	-52.26	55.27
EBIT	2.33	1.77	0.15	11.82	2.09
EBIT Growth (%)	31.58	1,108.72	-98.76	465.11	-76.75
Profit after Tax (PAT)	0.50	1.90	0.11	11.77	-2.12
PAT Growth (%)	-73.79	1,591.47	-99.04	-	-123.86
EBIT Margin (%)	7.47	5.92	0.50	38.05	4.93
Net Profit Margin (%)	1.60	6.35	0.38	37.89	-5.01
Basic EPS (₹)	0.24	0.90	0.05	5.59	-0.95

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	31.21	29.93	29.32	31.07	42.35
Total Income Growth (%)	4.28	2.09	-5.63	-26.64	21.18
Total Expenses	28.01	28.18	29.17	19.24	40.05
Total Expenses Growth (%)	-0.62	-3.39	51.62	-51.96	54.30
EBIT	3.21	1.75	0.15	11.83	2.30
EBIT Growth (%)	83.20	1,088.26	-98.75	414.35	-74.43
Profit after Tax (PAT)	1.36	1.87	0.10	11.78	-1.95
PAT Growth (%)	-27.62	1,752.57	-99.14	-	-121.90
EBIT Margin (%)	10.27	5.85	0.50	38.07	5.43
Net Profit Margin (%)	4.35	6.26	0.35	37.90	-4.60
Basic EPS (₹)	0.64	0.89	0.05	5.60	-0.86

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	121.57	135.80	123.63	102.32	123.04
Total Revenue Growth (%)	-10.48	9.84	20.82	-16.84	20.69
Total Expenses	104.87	110.13	102.95	86.43	103.48
Total Expenses Growth (%)	-4.78	6.98	19.11	-16.47	13.51
Profit after Tax (PAT)	14.13	19.50	16.78	12.58	14.09
PAT Growth (%)	-27.57	16.25	33.33	-10.71	94.45
Operating Profit Margin (%)	16.02	23.03	19.35	17.33	17.61
Net Profit Margin (%)	13.35	17.34	15.42	13.53	12.55
Basic EPS (₹)	6.71	9.34	8.01	5.88	6.70

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	121.53	135.76	123.61	102.36	123.06
Total Revenue Growth (%)	-10.48	9.82	20.76	-16.82	20.69
Total Expenses	104.89	109.92	102.94	86.43	103.48
Total Expenses Growth (%)	-4.57	6.78	19.10	-16.47	13.50
Profit after Tax (PAT)	14.95	19.68	16.78	12.62	14.13
PAT Growth (%)	-24.02	17.29	32.90	-10.63	94.45
Operating Profit Margin (%)	16.00	23.21	19.37	17.37	17.65
Net Profit Margin (%)	14.13	17.50	15.42	13.58	12.58
Basic EPS (₹)	6.69	9.42	8.01	5.90	6.71

All figures in Rs Cr, unless mentioned otherwise

Insights

Topline Contraction
Sales de-grew by 10.48%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 14.94% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	242.14	222.63	182.37	167.27	155.24
Total Assets Growth (%)	8.77	22.07	9.03	7.75	10.59
Total Liabilities	55.86	51.19	30.46	32.69	33.51
Total Liabilities Growth (%)	9.12	68.06	-6.82	-2.43	2.39
Total Equity	186.28	171.43	151.91	134.58	121.73
Total Equity Growth (%)	8.66	12.85	12.88	10.55	13.09
Current Ratio (x)	4.01	4.12	5.74	4.67	4.43
Total Debt to Equity (x)	0.01	0.00	0.03	0.02	0.05
Contingent Liabilities	0.00	6.65	10.57	3.25	5.28

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	251.38	232.98	192.42	177.50	165.14
Total Assets Growth (%)	7.90	21.08	8.41	7.48	9.92
Total Liabilities	54.80	51.18	30.45	32.98	33.50
Total Liabilities Growth (%)	7.07	68.08	-7.67	-1.55	2.42
Total Equity	196.58	181.80	161.97	144.53	131.64
Total Equity Growth (%)	8.13	12.24	12.07	9.79	12.01
Current Ratio (x)	4.06	4.10	5.70	4.95	4.78
Total Debt to Equity (x)	0.01	0.00	0.03	0.02	0.04
Contingent Liabilities	0.00	6.65	10.57	3.25	5.28

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	10.66	18.32	3.65	8.90	2.17
Net Cash used in Investing Activities	-12.27	-12.36	-13.34	2.13	-15.61
Net Cash flow from Financing Activities	2.22	-5.44	2.58	-3.79	5.43
Net Cash Flow	0.62	0.51	-7.10	7.24	-8.01
Closing Cash & Cash Equivalent	1.23	3.62	3.11	8.81	2.50
Closing Cash & Cash Equivalent Growth (%)	-65.96	16.47	-64.71	252.56	-76.24
Total Debt/ CFO (x)	0.24	0.00	1.44	0.26	2.69

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	11.48	18.39	3.70	8.82	2.20
Net Cash used in Investing Activities	-11.58	-12.49	-12.45	2.14	-17.18
Net Cash flow from Financing Activities	-1.16	-5.48	2.26	-3.48	5.41
Net Cash Flow	-1.26	0.43	-6.49	7.48	-9.57
Closing Cash & Cash Equivalent	1.83	3.05	3.66	10.13	0.67
Closing Cash & Cash Equivalent Growth (%)	-40.03	-16.63	-63.90	1,416.95	-93.49
Total Debt/ CFO (x)	0.13	0.00	1.42	0.29	2.65

All figures in Rs Cr, unless mentioned otherwise

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 10.66 cr is 0.75 times compared to the reported net profit of Rs 14.13 cr. (Source: Consolidated Financials)
Decrease in Cash from Investing
Company has used Rs 12.27 cr for investing activities which is an YoY decrease of 0.78%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	7.58	11.37	11.04	9.34	11.57
Return on Capital Employed (%)	8.94	14.72	13.63	11.90	15.97
Return on Assets (%)	5.83	8.76	9.19	7.52	9.07
Interest Coverage Ratio (x)	73.83	121.23	64.02	78.01	97.84
Asset Turnover Ratio (x)	0.46	0.56	0.62	0.58	0.73
Price to Earnings (x)	6.89	11.24	10.47	9.00	10.38
Price to Book (x)	0.52	1.28	1.16	0.84	1.20
EV/EBITDA (x)	5.09	7.72	7.79	6.11	6.98
EBITDA Margin (%)	18.00	24.98	21.14	18.76	19.09

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	7.60	10.82	10.35	8.73	10.73
Return on Capital Employed (%)	8.46	14.01	12.81	10.94	14.54
Return on Assets (%)	5.94	8.44	8.71	7.11	8.55
Interest Coverage Ratio (x)	65.11	106.31	59.13	78.27	88.43
Asset Turnover Ratio (x)	0.44	0.53	0.59	0.54	0.71
Price to Earnings (x)	6.51	11.14	10.47	8.97	10.36
Price to Book (x)	0.50	1.21	1.08	0.78	1.11
EV/EBITDA (x)	5.13	7.68	7.80	6.12	6.98
EBITDA Margin (%)	17.97	25.17	21.16	18.80	19.13

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Alpa Labs	9.96	0.76	7.58	8.94	5.83	5.85	16.02	13.35	6.71	4.01	0.01	0.24
Aarey Drugs	54.84	1.65	2.63	6.84	1.33	4.25	2.20	0.84	1.39	1.81	0.33	4.93
Brooks Labs	8.39	1.68	20.04	5.25	16.59	10.96	7.74	6.77	8.35	1.72	0.06	0.78
Natural Capsule	-7.03	0.69	-7.70	-5.82	-4.02	2.96	-9.06	-13.17	-23.84	1.03	0.52	10.47
Krebs Biochem	-8.22	-0.86	0.00	-19.62	-10.37	-21.07	-41.49	-71.35	-7.85	0.09	-1.38	-117.07
Add More

Annual Ratios (%)

Choose from Peers

Bal Pharma
Par Drugs & Chemical
Vaishali Pharma
Biofil Chem
Vivimed Labs

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Alpa Labs Stock Performance	-0.78	-0.91	-1.76	1.00	-36.85	14.93	19.61
Aarey Drugs Stock Performance	4.62	-4.21	-0.81	11.39	64.18	212.36	0.00
Brooks Labs Stock Performance	5.00	45.85	9.32	-5.99	-48.69	12.29	-27.15
Natural Capsule Stock Performance	-2.73	0.54	-2.48	-0.84	-21.20	0.00	0.00
Krebs Biochem Stock Performance	-1.53	14.18	5.01	10.20	-13.20	-0.42	-49.96
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	1,20,33,070	57.19 %	-0.10
Pledge	0	0.00 %	0.00
FII	80,840	0.38 %	0.02
Others	89,26,690	42.43 %	0.07

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	57.19	57.29	57.29	57.29
Pledge	0.00	0.00	0.00	0.00
FII	0.38	0.36	0.35	0.36
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	42.43	42.35	42.36	42.35

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results
May 12, 2026
Board Meeting
Quarterly Results
Jan 29, 2026
Board Meeting
Quarterly Results
Nov 04, 2025

Board Meetings

Announced on	Meeting on
May 12, 2026	May 29, 2026
Audited Results
Jan 29, 2026	Feb 11, 2026
Quarterly Results
Nov 04, 2025	Nov 14, 2025
Quarterly Results
Aug 01, 2025	Aug 13, 2025
Quarterly Results & A.G.M.
May 19, 2025	May 28, 2025
Audited Results

Dividends
No Data Available
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

AGM/EGM Meetings

Announced on	Meeting on
Sep 14, 2025	Sep 29, 2025
Book closure from Sep 22, 2025 to Sep 29, 2025
Sep 18, 2024	Sep 28, 2024
A.G.M.
Sep 20, 2023	Sep 29, 2023
A.G.M.
Aug 13, 2022	Sep 29, 2022
-
Sep 08, 2020	-
Book closure from Sep 22, 2020 to Sep 29, 2020

About Alpa Labs

Alpa Laboratories Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 142.19 Crore) operating in Pharmaceuticals sector.

Alpa Laboratories Ltd. key Products/Revenue Segments include Drugs & Pharmaceuticals, Export Incentives, Sale of services and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 31.24 Crore, up 4.27 % from last quarter Total Income of Rs 29.96 Crore and down 26.32 % from last year same quarter Total Income of Rs 42.40 Crore. Company has reported net profit after tax of Rs .50 Crore in latest quarter.

The company’s top management includes Mr.Mahendra Singh Chawla, Mr.Paresh Chawla, Mrs.Jyoti Jain, Mrs.Pratibha Lunawat, Mr.Pratik Shah, Mr.Sanket Baheti, Mr.Sunil Kumar Valecha, Mr.Pravin Shah, Mr.Shitul Shah, Mr.Vitthal Kothana, Mr.Bakulesh Shah, Ms.Srashti Chopra. Company has C H Padliya & Co. as its auditors. As on 31-03-2026, the company has a total of 2.10 Crore shares outstanding.

Alpa Labs Share Price Today is Rs. 67.58. On previous day, the Alpa Labs Share Price (NSE) closed at Rs. 67.86, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 57.19% of the stake in Alpa Labs shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Alpa Labs stocks was 0.38% as compared to 0.36% in Dec 2025 with increase of 0.02%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Alpa Labs shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Alpa Labs stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Alpa Labs Dividend: Ever since 1988, Alpa Labs dividends has been paid out around 0 times. As on 22 Jun, 2026, 03:45 PM IST, The overall dividend yield for Alpa Labs stands at 0.0%. The last dividend paid was on null (Rs. null). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 6.79.

Alpa Labs Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 31.24 Cr. of sales and 4.27% of quarterly net profit, there have been multiple ups and downs in the Alpa Labs stock prices in the past few weeks. For example, Alpa Labs stock price on 12th of June 2026 was around Rs. 69.69. Alpa Labs share price now stands at an average of Rs. 67.58. Judging by last week's performance, stock is in down trend.

Alpa Labs has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Alpa Labs share.

Historical Prices and Performance:
Alpa Labs, incorporated in 1988 is a Small Cap company (with a market cap of Rs. 143.31) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Alpa Labs stock was 7.58%, 11.37%, 11.04%, 9.34% and 11.57% respectively.
The Alpa Labs share gave a 3 year return of 4.95% as compared to Nifty 50 which gave a return of 28.03%.
Alpa Labs announced 0.0% final dividend on null.

Key Metrics:
PE Ratio of Alpa Labs is 10.03
Prices/Sales Ratio of Alpa Labs is 0.92
Price/Book Ratio of Alpa Labs is 0.77

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Alpa Labs, major competitors and peers include Aarey Drugs, Brooks Labs, Natural Capsule and Krebs Biochem. As of Dec 2025, the dividend yield of Alpa Labs stands at 0.0% while Aarey Drugs, Brooks Labs, Natural Capsule and Krebs Biochem stand at 0.0%, 0.0%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 10.03 and 0.77 respectively.

Leadership of Alpa Labs :
Bakulesh Shah is Chief Financial Officer
Srashti Chopra is Co. Secretary & Compl. Officer
Mahendra Singh Chawla is Chairman
Paresh Chawla is Managing Director
Pravin Shah is Director
Vitthal Kothana is Director
Shitul Shah is Director
Jyoti Jain is Independent Director
Sanket Baheti is Independent Director
Pratik Shah is Independent Director
Pratibha Lunawat is Independent Director
Sunil Kumar Valecha is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

-

Address

33/2, Pigdamber,A.B.Road, Rau,Indore, Madhya Pradesh - 453446

Contact

is@alpalabs.in

http://www.alpalabs.in

PE Ratio(x)	9.96
EPS - TTM(₹)	6.79
MCap(₹ Cr.)	142.19
MCap Rank	108
PB Ratio(x)	0.77
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	108.30
52W Low(₹)	46.10
MCap/Sales	0.92
Beta(1 Month)	-0.23
BV/Share(₹)	88.53

PE Ratio(x)	9.94
EPS - TTM(₹)	6.79
MCap(₹ Cr.)	141.98
MCap Rank	129
PB Ratio(x)	0.77
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	109.85
52W Low(₹)	46.00
MCap/Sales	0.92
Beta(1 Month)	-1.08
BV/Share(₹)	88.53

1 Day	-0.78%
1 Month	-2.28%
3 Months	12.32%
1 Year	-30.47%
3 Years	1.93%
5 Years	20.14%

1 Day	-0.58%
1 Month	-3.19%
3 Months	12.49%
1 Year	-30.99%
3 Years	2.49%
5 Years	19.75%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Alpa Labs - Alpa Laboratories Share Price

Key Metrics

Alpa Labs share price insights

Alpa Labs Share Price Returns

Alpa Labs Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Alpa Labs Top Searches

Corporate Actions

About Alpa Labs

Executive Leadership

Auditors

FAQs about Alpa Labs share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News